FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells

93Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Stimulation of B and T cells via the antigen receptor, by phorbol ester or by phorbol ester and ionomycin, leads to nuclear translocation of the inducible transcription factor NF-κB, comprising the p50 and p65 rel- related polypeptides. In this report we show that c-rel is a component of the antigen receptor-induced κB binding proteins in both B and T cells. Whereas NF-κB can be induced by phorbol ester alone, optimal induction of c-rel requires stimulation by both phorbol ester and ionomycin, the dual signal that is necessary for proliferation of untransformed lymphocytes. Furthermore, c-rel induction is blocked by the immunosuppressive drug FK506 that is known to inhibit B and T cell activation. c-rel-dependent transactivation of the interleukin-2 receptor α chain (IL-2Rα) promoter is augmented by coexpression of calcineurin, suggesting the involvement of a calcineurin-dependent intracellular pathway. Our results identify c-rel as a target of immunosuppressive agents and illustrate the similarity of activation pathways in both B and T cells.

Cite

CITATION STYLE

APA

Venkataraman, L., Burakoff, S. J., & Sen, R. (1995). FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. Journal of Experimental Medicine, 181(3), 1091–1099. https://doi.org/10.1084/jem.181.3.1091

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free